NSE: MEDANTA · 27 October 2026
- Global Health Ltd. (MEDANTA) advanced 3.84% today, trading near the upper end of its intraday range between ₹1,205.10 and ₹1,272.20 after opening slightly softer at ₹1,208.30.
- The company announced receipt of a 'Crisil ESG 64' rating and a Core ESG rating of 'Crisil Core ESG 70' for fiscal year 2026 from Crisil ESG Ratings & Analytics Limited. The communication was formally received following the close of working hours on October 1, 2026.
- Trading volume was 0.48 times the 20-day average daily volume.
Why is Global Health share price rising on 27 October 2026?
Global Health Ltd. (MEDANTA) advanced 3.84% today, trading near the upper end of its intraday range between ₹1,205.10 and ₹1,272.20 after opening slightly softer at ₹1,208.30.
The broader healthcare sector outperformed during the session, with the Nifty Pharma index gaining 2.06% while the broader Nifty benchmark remained flat at -0.02%. Medanta's positive price action coincided with this sectoral strength, building on prior session returns of 2.28% and 1.15% over the preceding two trading days, though the stock remains down 15.84% over a 20-day horizon.
While the company recently disclosed an ESG rating of Crisil ESG 64 and Core ESG 70 on October 5, and an allotment of 2,750 equity shares under its employee incentive plan on October 23, these routine updates do not represent a direct trading catalyst for today's move. Market participants are also noting the upcoming second-quarter and half-year financial results scheduled for board review on November 3, 2026.
1.12 lakh shares traded by 27 October 2026 · 02:55 PM IST. This compares with a 20-day average daily volume of 2.31 lakh shares (0.48 times). The five-day average daily volume was 2.23 lakh shares. Separately, the NSE report for 26 October 2026 showed 27,715 shares delivered, representing 35.22% of that day’s traded volume. The same report recorded 9,193 trades.
Today's upward movement appears consistent with broader Nifty Pharma sector strength and a continuation of short-term recovery following recent weeks of correction, in the absence of any same-day fundamental catalyst.
Latest Company Developments
The company announced receipt of a 'Crisil ESG 64' rating and a Core ESG rating of 'Crisil Core ESG 70' for fiscal year 2026 from Crisil ESG Ratings & Analytics Limited. The communication was formally received following the close of working hours on October 1, 2026.
Provides institutional investors with an external benchmark of the company's environmental, social, and governance practices.
Global Health Limited announced the acquisition of a 10,560 square metre freehold land parcel at Siddharth Vihar Yojna, Ghaziabad, through an online auction by the Uttar Pradesh Housing & Development Board for approximately ₹165.82 crore. The site has the potential to house a 350+ bedded hospital, subject to statutory approvals and board sanction.
Expands the healthcare provider's presence within the high-growth Delhi-NCR regional market.
a press release dated July 30, 2026, titled "Press release for the Results of First Quater ended June 30, 2026".
a press release dated September 29, 2026, titled "Medanta to expand Healthcare Footprint in Uttar Pradesh with the Acquisition of 10,560 Sq. Metre Land Parcel in Ghaziabad.".
'Global Health Limited has informed the exchage about date for payment of Dividend'.
Ownership & Transaction Activity
Mutual Fund Holdings
Mutual funds held 15.97% on 30 September 2026. This compares with 16.03% on 30 June 2026, a change of -0.06 percentage points.
The filing reported 30 MF/UTI holders.
Research & Brokerage Views
Initiated coverage noting that Medanta expanded beds by 47% while maintaining rising occupancy levels, prompting an evaluation of margin catch-up potential.
Historical Bulk / Block Deals
What to Watch Next
- Upcoming Q2 and half-year financial results scheduled for board review on November 3, 2026
- Execution progress on the recently acquired 10,560 sq. metre land parcel in Ghaziabad for the proposed 350+ bed hospital
- Cash volume participation and delivery percentage trends relative to the 20-day average volume
- Margin performance and occupancy metrics across operational tertiary care facilities
More Global Health news and dated analysis →
Frequently Asked Questions
What is the latest Global Health company news?
The company announced receipt of a 'Crisil ESG 64' rating and a Core ESG rating of 'Crisil Core ESG 70' for fiscal year 2026 from Crisil ESG Ratings & Analytics Limited. The communication was formally received following the close of working hours on October 1, 2026.
How strong was Global Health’s trading volume?
1.12 lakh shares traded, 0.48 times the 20-day average daily volume. The price and volume data are dated 27 October 2026 · 02:55 PM IST.
Do the mutual-fund figures show buying today?
They show holdings on 30 September 2026. Quarterly holdings do not identify purchases made on the article date.
Research & analysis: WittyTrades Research Desk
Reviewed by: Mohanish Sanghavi — SEBI Registered Research Analyst
Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.